Macroplane › Companies › GeneDx Holdings Corp.

GeneDx Holdings Corp. (WGS)

Sector: Services-Health Services · Industry: Diagnostics & Research · Exchange: Nasdaq

About GeneDx Holdings Corp.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Headquarters: Stamford, CT · Employees: 1300 · Website: https://www.genedx.com

Supply-chain relationships for WGS

  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) — supplier

Frequently asked questions about GeneDx Holdings Corp. (WGS)

What is GeneDx Holdings Corp. (WGS)?

GeneDx Holdings Corp. (WGS) is a publicly traded company in the Services-Health Services sector (Diagnostics & Research), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are GeneDx Holdings Corp.'s key suppliers and customers?

Macroplane tracks GeneDx Holdings Corp.'s (WGS) supply chain. Key suppliers include PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).

Search companies · Macro trends · Industries · Product categories · Baskets